Pinsent Masons advises the UK government on purchase of further 60m doses of Covid-19 vaccines
10 May 2021 | 09:36 am |
Multinational law firm Pinsent Masons has successfully advised the UK government on an agreement to purchase an additional 60m doses of the Pfizer BioNTech Covid-19 vaccine for the autumn revaccination programme.
The team at Pinsent Masons was led by Life Sciences transactions partner Allistair Booth and included Andy Cornforth, Niki Ruprai, Robert Sherville-Payne and Aaron Hope.
Commenting on the agreement, Allistair Booth, lead partner at Pinsent Masons said:
"This is an important agreement. Access to 60m doses of that vaccine in time for an autumn revaccination programme will hopefully play a key role in protecting the NHS and the most vulnerable people of the UK.
"We are proud to have worked with the UK government on securing this agreement for such an important vaccine at such a crucial time".
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises Horizon 3 Healthcare on investment in Xeltis
Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.
Pinsent Masons appoints inaugural financial regulatory consulting head
Multinational law firm Pinsent Masons has hired Ian Stott to found and lead its financial regulatory consulting practice. Ian will join Vario, the legal services delivery arm of Pinsent Masons, and work with specialists across the firm to enhance existing offerings and spearhead the development of its non-legal regulatory conduct and financial crime advisory and remediation services.
Pinsent Masons elects John Maciver as Senior Partner
Multinational law firm Pinsent Masons has elected John Maciver as Senior Partner.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises Horizon 3 Healthcare on investment in Xeltis
Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.
Pinsent Masons elects John Maciver as Senior Partner
Multinational law firm Pinsent Masons has elected John Maciver as Senior Partner.
Pinsent Masons strengthens its competition law practice with the appointment of Christian Peeters
Multinational law firm Pinsent Masons is strengthening its Antitrust, Competition & Trade practice at its Dusseldorf/Germany office with the appointment of Christian Peeters, LL.M., effective 1 July 2026.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]